Your browser doesn't support javascript.
loading
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
Kimura, Izumi; Yamasoba, Daichi; Nasser, Hesham; Ito, Hayato; Zahradnik, Jiri; Wu, Jiaqi; Fujita, Shigeru; Uriu, Keiya; Sasaki, Jiei; Tamura, Tomokazu; Suzuki, Rigel; Deguchi, Sayaka; Plianchaisuk, Arnon; Yoshimatsu, Kumiko; Kazuma, Yasuhiro; Mitoma, Shuya; Schreiber, Gideon; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Takaori-Kondo, Akifumi; Ito, Jumpei; Shirakawa, Kotaro; Takayama, Kazuo; Irie, Takashi; Hashiguchi, Takao; Nakagawa, So; Fukuhara, Takasuke; Saito, Akatsuki; Ikeda, Terumasa; Sato, Kei.
Affiliation
  • Kimura I; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Yamasoba D; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Nasser H; Faculty of Medicine, Kobe University , Kobe, Japan.
  • Ito H; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University , Kumamoto, Japan.
  • Zahradnik J; Department of Clinical Pathology, Faculty of Medicine, Suez Canal University , Ismailia, Egypt.
  • Wu J; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan.
  • Fujita S; Department of Biomolecular Sciences, Weizmann Institute of Science , Rehovot, Israel.
  • Uriu K; First Medical Faculty at Biocev, Charles University , Vestec-Prague, Czechia.
  • Sasaki J; Department of Molecular Life Science, Tokai University School of Medicine , Isehara, Japan.
  • Tamura T; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Suzuki R; Graduate School of Medicine, The University of Tokyo , Tokyo, Japan.
  • Deguchi S; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Plianchaisuk A; Graduate School of Medicine, The University of Tokyo , Tokyo, Japan.
  • Yoshimatsu K; Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University , Kyoto, Japan.
  • Kazuma Y; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan.
  • Mitoma S; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University , Sapporo, Japan.
  • Schreiber G; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan.
  • Asakura H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University , Sapporo, Japan.
  • Nagashima M; Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, Japan.
  • Sadamasu K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Yoshimura K; Institute for Genetic Medicine, Hokkaido University , Sapporo, Japan.
  • Takaori-Kondo A; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto, Japan.
  • Ito J; Graduate School of Medicine and Veterinary Medicine, University of Miyazaki , Miyazaki, Japan.
  • Shirakawa K; Department of Biomolecular Sciences, Weizmann Institute of Science , Rehovot, Israel.
  • Takayama K; Tokyo Metropolitan Institute of Public Health , Tokyo, Japan.
  • Irie T; Tokyo Metropolitan Institute of Public Health , Tokyo, Japan.
  • Hashiguchi T; Tokyo Metropolitan Institute of Public Health , Tokyo, Japan.
  • Nakagawa S; Tokyo Metropolitan Institute of Public Health , Tokyo, Japan.
  • Fukuhara T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto, Japan.
  • Ikeda T; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Sato K; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
J Virol ; 97(10): e0101123, 2023 10 31.
Article in En | MEDLINE | ID: mdl-37796123
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Viral / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / Mutation Limits: Humans Language: En Journal: J Virol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Viral / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / Mutation Limits: Humans Language: En Journal: J Virol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos